Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 24.490
- +0.360+1.49%
Close Feb 14 16:00 ET
- 24.490
- 0.0000.00%
Post 16:00 ET
724.83MMarket Cap-10.72P/E (TTM)
25.455High23.610Low332.87KVolume24.500Open24.130Pre Close8.13MTurnover2.75%Turnover RatioLossP/E (Static)29.60MShares33.77052wk High2.15P/B296.53MFloat Cap18.34552wk Low--Dividend TTM12.11MShs Float336.000Historical High--Div YieldTTM7.65%Amplitude5.136Historical Low24.438Avg Price1Lot Size
About Dianthus Therapeutics Company
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Company Profile
SymbolDNTH
Company NameDianthus Therapeutics
Listing DateJun 21, 2018
Founded2015
CEOMr. Marino Garcia
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address7 Times Square,43rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-929-999-4055
Websitehttp://dianthustx.com
Company Executives
- Name
- Position
- Salary
- Marino Garcia
- President, Chief Executive Officer and Director
- --
- Edward G. Carr
- Chief Accounting Officer
- --
- Ryan Savitz
- Chief Financial Officer, Chief Business Officer and Treasurer
- --
- Dr. Simrat Randhawa, M.D.
- Chief Medical Officer
- --
- Adam M. Veness
- Senior Vice President, General Counsel and Secretary
- --
- Leon O. Moulder, Jr
- Chairman of the Board
- --
- Dr. Steven Joseph Romano, M.D.
- Director
- --
- Dr. Jonathan Violin, M.B.A.,PhD
- Director
- --
- Anne M. McGeorge
- Independent Director
- --
- Alison F. Lawton
- Independent Director
- --
- Tomas Kiselak
- Independent Director
- --
- Paula Soteropoulos
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.